Marathon Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-750
| Closed | -$269K | – | 171 |
|
|
2021
Q4 | $269K | Hold |
750
| – | – | 0.06% | 144 |
|
|
2021
Q3 | $245K | Hold |
750
| – | – | 0.06% | 191 |
|
|
2021
Q2 | $234K | Sell |
750
-30
| -4% | -$9.36K | 0.05% | 173 |
|
|
2021
Q1 | $248K | Hold |
780
| – | – | 0.07% | 157 |
|
|
2020
Q4 | $252K | Buy |
780
+5
| +0.6% | +$1.62K | 0.07% | 125 |
|
|
2020
Q3 | $214K | Buy |
+775
| New | +$214K | 0.08% | 129 |
|
|
2019
Q2 | – | Sell |
-780
| Closed | -$222K | – | 118 |
|
|
2019
Q1 | $222K | Hold |
780
| – | – | 0.1% | 88 |
|
|
2018
Q4 | $253K | Buy |
780
+30
| +4% | +$9.73K | 0.13% | 79 |
|
|
2018
Q3 | $337K | Sell |
750
-149
| -17% | -$67K | 0.13% | 76 |
|
|
2018
Q2 | $367K | Sell |
899
-101
| -10% | -$41.2K | 0.14% | 69 |
|
|
2018
Q1 | $290K | Buy |
+1,000
| New | +$290K | 0.11% | 78 |
|